30 Sept 2026, 17:18
Director Interests—
RHYRHYTHM BIOSCIENCES LIMITED
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 16:52
Company Administration—
29 Sept 2026, 16:51
Financial Results—
29 Sept 2026, 12:09
Meetings & Governance—
29 Sept 2026, 08:11
Company Administration—
22 Sept 2026, 08:24
Company UpdateMS
28 Aug 2026, 15:07
Director Interests—
28 Aug 2026, 15:06
Director Interests—
27 Aug 2026, 17:04
Financial ResultsMS
26 Aug 2026, 08:07
Company Administration—
21 Aug 2026, 13:01
Securities Administration—
20 Aug 2026, 08:40
Company Update—
6 Aug 2026, 08:38
Presentations—
30 July 2026, 08:33
Quarterly ReportsMS
21 July 2026, 08:30
Company Update—
7 July 2026, 08:26
Presentations—
2 July 2026, 08:24
Company Update—
4 June 2026, 08:24
Presentations—
26 May 2026, 08:49
Company Update—
13 May 2026, 10:08
Presentations—
6 May 2026, 08:28
Company Update—
5 May 2026, 11:04
Presentations—
30 Apr 2026, 09:31
Quarterly ReportsMS
28 Apr 2026, 17:24
Company Administration—
17 Apr 2026, 16:28
Securities Administration—
15 Apr 2026, 17:04
Securities Administration—
15 Apr 2026, 16:45
Securities Administration—
14 Apr 2026, 16:53
ASX QueryMS
14 Apr 2026, 15:32
Securities Administration—
7 Apr 2026, 16:39
Director Interests—
7 Apr 2026, 16:35
Securities Administration—
2 Apr 2026, 17:43
Securities Administration—
2 Apr 2026, 17:41
Securities Administration—
31 Mar 2026, 09:25
Securities Administration—
30 Mar 2026, 08:40
Securities Administration—
30 Mar 2026, 08:23
Company Update—
27 Mar 2026, 16:31
Securities Administration—
26 Mar 2026, 08:31
Company Update—
20 Mar 2026, 16:52
Securities Administration—
18 Mar 2026, 08:36
Company Update—
18 Mar 2026, 08:26
Presentations—
13 Mar 2026, 12:47
Securities Administration—
12 Mar 2026, 09:16
Presentations—
11 Mar 2026, 08:28
Company UpdateMS
9 Mar 2026, 09:10
Company UpdateMS
6 Mar 2026, 10:07
Securities Administration—
4 Mar 2026, 08:57
Company UpdateMS
27 Feb 2026, 16:27
Securities Administration—
27 Feb 2026, 16:22
Securities Administration—
27 Feb 2026, 10:06
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 17:18 | Final Director's Interest Notice - Gavin Fox-Smith | Director Interests | — | 02010 | |
| 29 Sept 2026, 16:52 | FY26 Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 29 Sept 2026, 16:51 | FY26 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 29 Sept 2026, 12:09 | AGM date and closing date for director nominations | Meetings & Governance | — | 08006 | |
| 29 Sept 2026, 08:11 | Board Changes | Company Administration | — | 12001 | |
| 22 Sept 2026, 08:24 | Initial ColoSTAT Assessment in UK opens new market access | Company Update | MS | 11001 | |
| 28 Aug 2026, 15:07 | Initial Director's Interest Notice - Carl Stubbings | Director Interests | — | 02008 | |
| 28 Aug 2026, 15:06 | Initial Director's Interest Notice - Maureen Baker | Director Interests | — | 02008 | |
| 27 Aug 2026, 17:04 | FY26 Appendix 4E & Audited Financial Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 08:07 | Appointment of Non-Executive Directors | Company Administration | — | 12001 | |
| 21 Aug 2026, 13:01 | Notification of cessation of securities - RHY | Securities Administration | — | 06027 | |
| 20 Aug 2026, 08:40 | ColoSTAT Commercial Rollout Update | Company Update | — | 11001 | |
| 6 Aug 2026, 08:38 | Bioshares 2026 Presentation | Presentations | — | 03026 | |
| 30 July 2026, 08:33 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 21 July 2026, 08:30 | New Lung Cancer Genetype Risk Assessment Test | Company Update | — | 11001 | |
| 7 July 2026, 08:26 | Accreditation Matters Conference Presentation | Presentations | — | 03026 | |
| 2 July 2026, 08:24 | Rhythm launches tailored ColoSTAT marketing campaign | Company Update | — | 11001 | |
| 4 June 2026, 08:24 | Rhythm Bio Singapore Investor Presentation | Presentations | — | 03026 | |
| 26 May 2026, 08:49 | ColoSTAT Access Program Gains Momentum | Company Update | — | 11001 | |
| 13 May 2026, 10:08 | Investor Presentation | Presentations | — | 03026 | |
| 6 May 2026, 08:28 | ColoSTAT Demonstrates Early Clinical Adoption | Company Update | — | 11001, 14014 | |
| 5 May 2026, 11:04 | Investor Webinar | Presentations | — | 14014 | |
| 30 Apr 2026, 09:31 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 17:24 | RHYO Underwriting Update | Company Administration | — | 06009, 12008 | |
| 17 Apr 2026, 16:28 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 15 Apr 2026, 17:04 | Cleansing Notice | Securities Administration | — | 06018 | |
| 15 Apr 2026, 16:45 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 14 Apr 2026, 16:53 | Response to ASX Query Letter | ASX Query | MS | 17003 | |
| 14 Apr 2026, 15:32 | Completion Of RHYO Option Underwriting | Securities Administration | — | 06009 | |
| 7 Apr 2026, 16:39 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 7 Apr 2026, 16:35 | Notification of cessation of securities - RHY | Securities Administration | — | 06027 | |
| 2 Apr 2026, 17:43 | Proposed issue of securities - RHY | Securities Administration | — | 06013 | |
| 2 Apr 2026, 17:41 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 31 Mar 2026, 09:25 | RHYO Options Underwriting Agreement | Securities Administration | — | 06009 | |
| 30 Mar 2026, 08:40 | Prospectus | Securities Administration | — | 06010 | |
| 30 Mar 2026, 08:23 | Rapid Expansion of ColoSTAT Commercial Roll Out | Company Update | — | 11001 | |
| 27 Mar 2026, 16:31 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 26 Mar 2026, 08:31 | First geneType Clinical Test Sale in South East Asia | Company Update | — | 11001 | |
| 20 Mar 2026, 16:52 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 18 Mar 2026, 08:36 | Accelerating the Commercial Rollout of ColoSTAT | Company Update | — | 11001 | |
| 18 Mar 2026, 08:26 | Investor Webinar Presentation | Presentations | — | 03026 | |
| 13 Mar 2026, 12:47 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 12 Mar 2026, 09:16 | Investor Webinar | Presentations | — | 14014 | |
| 11 Mar 2026, 08:28 | First ColoSTAT Clinical Test Sale | Company Update | MS | 11001 | |
| 9 Mar 2026, 09:10 | NATA Accredits ColoSTAT Clinical Testing Service | Company Update | MS | 11001 | |
| 6 Mar 2026, 10:07 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 4 Mar 2026, 08:57 | RHY Executes SE Asian Genetype Distribution Agreement | Company Update | MS | 11001 | |
| 27 Feb 2026, 16:27 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 Feb 2026, 16:22 | Application for quotation of securities - RHY | Securities Administration | — | 06020 | |
| 27 Feb 2026, 10:06 | Application for quotation of securities - RHY | Securities Administration | — | 06020 |
1–50 of 122
1 / 3